Journal of Pathology Clinical Research

Papers
(The median citation count of Journal of Pathology Clinical Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement40
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer36
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma35
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes33
Issue Information31
Characterizing the tumor microenvironment in rare renal cancer histological types31
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach30
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements26
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy23
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway23
Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer23
Issue Information22
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis20
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer19
Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma18
17
Issue Information17
KRAS mutations and endometriosis burden of disease16
16
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer15
Authors' reply: Re: Koga et al. Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models15
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers15
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study14
14
Increased diagnostic sensitivity of palpation‐guided thyroid nodule fine‐needle aspiration cytology by BRAF V600E‐mutation analysis13
Pathologic T1 and T2 encapsulated invasive carcinomas arising from mucinous cystic neoplasms of the pancreas have favorable prognosis and might be treated conservatively12
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma12
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis12
11
Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation11
Engineering the future of 3D pathology11
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization11
Issue Information11
11
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression10
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study10
The ethical challenges of artificial intelligence‐driven digital pathology10
Automated annotations of epithelial cells and stroma in hematoxylin–eosin‐stained whole‐slide images using cytokeratin re‐staining9
Issue Information9
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome9
Issue Information9
9
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma9
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer9
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p8
8
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials8
Issue Information8
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types8
7
More than just acral melanoma: the controversies of defining the disease7
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma7
Exosome‐derived ANXA9 functions as an oncogene in breast cancer7
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors7
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors6
Closing the loop – the role of pathologists in digital and computational pathology research6
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors6
DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics6
Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric aden6
Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis6
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells6
Dysbalance of ACE2 levels – a possible cause for severe COVID‐19 outcome in COPD6
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior5
Issue Information5
Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets5
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells5
Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists4
Explainability and causability in digital pathology4
4
Mesonephric‐type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX24
4
Issue Information4
Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression4
Low gamma‐butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach4
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis4
Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images4
PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules4
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies4
4
ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features4
4
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐1194
Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes4
3
Issue Information3
Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer3
Reducing the risks of nuclear war – the role of health professionals3
CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma3
The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma3
Large multimodal model‐based standardisation of pathology reports with confidence and its prognostic significance3
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer3
AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer3
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma3
Genome‐wide analysis of mRNA and microRNA expression in colorectal cancer and adjacent normal mucosa3
Subtype‐associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms3
Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes3
Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell car3
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading3
DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’2
Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma2
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis2
2
Issue Information2
A novel NGS‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients2
Dynamic tuft cell expansion during gastric metaplasia and dysplasia2
Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models2
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing2
Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer2
Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues2
Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR‐rearranged family2
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy2
Diagnosing adult and pediatric extrapulmonary tuberculosis by MPT64 antigen detection with immunohistochemistry and immunocytochemistry using reproduced polyclonal antibodies2
CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma2
Issue Information2
2
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance2
Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning2
0.05609393119812